Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermat... (bout Melanoma Malignant melanoma is t...)

HOME >> MEDICINE >> TECHNOLOGY

Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology

Date:9/5/2007

bout Melanoma

Malignant melanoma is the most deadly form of skin cancer. The incidence of this disease is increasing by approximately 4% annually in the U.S. In 2004, the American Cancer Society estimates more than 55,000 cases of malignant melanoma will have been diagnosed. Melanoma is the number one cause of cancer death in women aged 25 to 29. More information about melanoma can be accessed at the Melanoma Research Foundation: http://www.melanoma.org.

About the EADO

The EADO is an international cooperative group dedicated to promote, coordinate and improve clinical and laboratory research activities in skin cancer. Further information about the EADO can be viewed at: http://www.eado.org/.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements wit
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
5. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
8. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology

Post Your Comments:

(Date:12/16/2009)... group of national medical societies launched a multi-state advertising ... and Affordable Care Act, currently under consideration by the ... vote in the coming days. The groups are ... health care bill that is "bad medicine" for patients. ... care system needs reform - but the current Senate ...

(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...

(Date:12/16/2009)... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online U.S. ... in 12% per annum short term debt financing. ... drawdown of $500,000, with accrued interest and principal repayable ... accrued interest and principal repayable in one year from ... positive for any calendar month prior to December 15, ...

Breaking Medicine Technology:Physician Groups Oppose Current Senate Health Care Reform Bill 2 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3 HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2 Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 1 Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 2 Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 3 BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1 BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2 BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3 BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 1 BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 2

[0] Physician Groups Oppose Current Senate Health Care Reform Bill [0] Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics [0] HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing

... the Treatment,s ,Low Rates of Morbidity, IRVINE, ... ), an innovative medical device company focused on ... and,interventional radiologists for tissue and tumor ablation, announced ... morbidity" in the,July issue of Urology Times. Focal ...

... Mean the End of Anti-Amyloid,Therapies -, CHICAGO, ... new treatments for Alzheimer,s - even an unsuccessful ... and point scientists,toward advances in therapies for the ... Alzheimer,s Association International Conference,on Alzheimer,s Disease (ICAD 2008), ...

Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008 Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation

(Date:12/17/2009)... Effective, low-cost service gets businesses listed on search engines like Google ... simple and affordable Web presence with SEO Local Registration service offered ... ... New Orleans, LA (PRWEB) December 17, 2009 -- In order to ... it a website or a listing on a local map section ...

(Date:12/17/2009)... new marketing techniques, life coaching company puts free i-phone ... worldwide!, http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... 2009 -- Utah based Attainment Life Management & Coaching ... want everything in life simplified into one little hand ...

(Date:12/16/2009)... Austin,s Custom Tops , a local business specializing ... and Hill Country Home Health, a slider-eating throwdown at ... Fifty people showed up to cheer on the two ... sliders in support of the local charity, The Austin ... bet over who could eat the most burgers became ...

(Date:12/16/2009)... Every year in the United States, 160,000 cases of ... the disease, making it the second leading cause of ... As researchers and clinicians fervently look for causes and ... studies producing more and more promising results Dr. ... at Case Western Reserve University School of Medicine and ...

(Date:12/16/2009)... CHICAGO, Dec. 16 Allscripts (Nasdaq: ... its financial results for the three and six ... market opens on Monday, January 11, 2010. Allscripts ... to discuss the company,s earnings and other information ... morning. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, ...

Breaking Medicine News(10 mins):Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2 Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2 Health News:Austin-Based Business Co-Sponsors Gastric Feat for Charity 2 Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2 Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4

[0] New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web [0] Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users [0] Austin-Based Business Co-Sponsors Gastric Feat for Charity [0] New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer'[0] Allscripts to Announce Second Quarter Fiscal 2010 Results

... million in annual revenues and eight locations in New Jersey, ... Connecticut, and Pennsylvania -, ... ), a leading regional provider of home health nursing,services, today announced ... Patient Care, Inc. This acquisition, the Company,s,largest to date, expands Almost ...

... to raise awareness of, Benign Prostatic Hyperplasia (BPH), a condition ... ... 19 Hall of Fame third,baseman and Philadelphia Phillies legend Mike Schmidt ... Starts with U:,Catch the Whole Game campaign, a program in the U.S. ...

... been told that exposure to radiation is dangerous. In high ... to the development of cancer. But, what if a short-term ... for our health. Writing in today,s issue of the Inderscience ... Luckey, makes the startling claim that low dose radiation could ...

... June 17 NeoMend, Inc. today announced,that its ... from the U.S. Food and Drug Administration,s (FDA) ... panel,s recommendation will be considered by the FDA ... (PMA) for ProGEL. The,panel,s recommendation for FDA approval ...

... BOSTON--Patients diagnosed with colon cancer who had abundant vitamin D ... follow-up period than those who were deficient in the vitamin, ... Institute. , The findings of the study -- the first ... patients -- merit further research, but it is too early ...

... ... Officers in MedeFile System During National ... Police Week, CEDAR ... specializing in,portable electronic medical records management solutions, today announced,that in collaboration with the ...

Other Medicine News:Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 2 Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 3 Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 4 Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 2 Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 3 Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 4 Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 5 Health News:Radiation for health 2 Health News:Radiation for health 3 Health News:NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant 2 Health News:Study links vitamin D to colon cancer survival 2 Health News:MedeFile International Teams with Newark Fraternal Order of Police 2 Health News:MedeFile International Teams with Newark Fraternal Order of Police 3 Health News:MedeFile International Teams with Newark Fraternal Order of Police 4

Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc.Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men Radiation for health NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant Study links vitamin D to colon cancer survival MedeFile International Teams with Newark Fraternal Order of Police

Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....

... most complex grinding formula to ... lens, are specifically manufactured to ... precision as the lenses used ... refractor. Marco custom trial lens ...

Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....

This is a reduced form of the 100 Hue test and is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score. Kit includes 100 score pads....

Medicine Products:

Ophtho-Burr Kit (5082) Ssk Custom Trial Lens Set Non-Illuminated Trial Lens Set L'Anthony 40 Hue Test

Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermat...(bout Melanoma Malignant melanoma is t...),Health